Korbmacher, F.; Fleckenstein, H.; Long, R. K. M.; Polinski, P.; Piatti, L.; Lopez Gutierrez, B.; Batzilla, A.; Crusius, D.; Trivedi, V.; Ebisuya, M.; Bernabeu, M.

The sequestration of the malaria parasite Plasmodium falciparum in the microvasculature is a major driver of severe malaria, but its pathogenic mechanisms still remain unknown. Advancements in induced pluripotent stem cells (iPSCs) technologies offer unique opportunities to study parasite interactions with microvessels in a well-defined host environment. However, endothelial iPSC-differentiation methods often result in cells with mixed-epithelial identity. Here, we have generated an iPSC line with inducible and simultaneous expression of ETS transcription factors (ETV2, FLI1, ERG), which resulted in improved endothelial cell identity and strong barrier function. These cells present a high affinity to infected red blood cells. Exposure of parasite products caused significant endothelial metabolic changes and splicing alterations. Furthermore, it caused iPSC-endothelial barrier disruption, as a consequence of transcriptional downregulation of key barrier processes, and alteration of severe malaria biomarkers. Our novel iPSC-approach represents a new in vitro platform to study the pathogenesis of vascular infections.